International Journal of Hepatology

Scope & Guideline

Bridging research and clinical practice in hepatology.

Introduction

Delve into the academic richness of International Journal of Hepatology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2090-3448
PublisherHINDAWI LTD
Support Open AccessYes
CountryEgypt
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINT J HEPATOL / Int. J. Hepatol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The International Journal of Hepatology focuses on advancing the understanding of liver diseases through empirical research and clinical studies. It covers a wide range of topics related to hepatology, emphasizing both fundamental research and clinical implications.
  1. Noninvasive Diagnostic Techniques:
    The journal frequently publishes studies evaluating noninvasive methods for diagnosing liver conditions, which are crucial for improving patient care and reducing the need for invasive procedures.
  2. Liver Transplantation and Management:
    Research related to liver transplantation, including donor-recipient compatibility, postoperative outcomes, and management strategies for transplant patients, is a significant focus area.
  3. Chronic Viral Hepatitis:
    The journal addresses chronic viral hepatitis, particularly Hepatitis B and C, including studies on epidemiology, treatment outcomes, and public health implications.
  4. Liver Cancer Research:
    A substantial portion of the research is dedicated to hepatocellular carcinoma, exploring its pathology, treatment options, and prognostic markers.
  5. Metabolic Liver Diseases:
    The journal covers metabolic-associated liver diseases such as Nonalcoholic Fatty Liver Disease (NAFLD) and its progression, highlighting the role of metabolic factors in liver pathologies.
  6. Patient Education and Awareness:
    Studies that assess knowledge, attitudes, and practices regarding liver health among healthcare professionals and the general public are also included, emphasizing the importance of education in disease prevention.
Recent publications in the International Journal of Hepatology reveal several emerging trends and themes that reflect the evolving landscape of liver disease research. These trends indicate a growing focus on innovative approaches and interdisciplinary studies.
  1. Integration of Biomarkers in Diagnosis and Prognosis:
    There is an increasing emphasis on identifying and validating new biomarkers, such as miRNAs and glycosylation markers, for diagnosing and predicting liver disease progression.
  2. Impact of Comorbid Conditions:
    Recent studies are exploring the interplay between liver disease and other comorbidities, such as kidney disease and HIV, highlighting the need for comprehensive management strategies.
  3. Public Health Initiatives for Viral Hepatitis:
    Emerging themes include the effectiveness of public health initiatives aimed at screening and treating chronic hepatitis, particularly in underserved populations and high-risk groups.
  4. Metabolic Factors in Liver Disease Progression:
    Research focusing on the metabolic aspects of liver diseases, including the role of obesity and metabolic syndrome in conditions like NAFLD, is gaining traction.
  5. Patient-Centric Care Approaches:
    There is a growing trend towards patient-centered research, assessing patient attitudes and practices regarding liver health, which is crucial for improving health outcomes.

Declining or Waning

While the journal actively covers a broad spectrum of hepatology topics, certain areas have shown a declining trend in publication frequency. This may reflect shifts in research focus or advancements in understanding specific conditions.
  1. Acute Liver Failure Research:
    There has been a noticeable decrease in studies specifically addressing acute liver failure, which may indicate a shift towards more chronic liver disease research.
  2. Traditional Hepatotoxicity Studies:
    Research focusing solely on traditional hepatotoxic agents has diminished as newer insights into liver injury mechanisms and nontraditional agents gain prominence.
  3. Hepatitis E and Other Less Common Viral Hepatitis:
    Publications on Hepatitis E and other less common forms of viral hepatitis have decreased, possibly due to a growing focus on more prevalent conditions like Hepatitis B and C.
  4. Invasive Diagnostic Procedures:
    Research on invasive diagnostic techniques has become less common as noninvasive methods gain acceptance and demonstrate efficacy in clinical settings.

Similar Journals

JGH Open

Pioneering Open Access in Gastroenterology and Hepatology
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Translational Gastroenterology and Hepatology

Bridging Discovery and Care in Gastroenterology.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

JHEP Reports

Bridging research and application for a healthier tomorrow.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Elevating standards in gastrointestinal and liver disease research.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Journal of Gastrointestinal and Liver Diseases

Exploring Innovations in Digestive Medicine
Publisher: MEDICAL UNIV PRESSISSN: 1841-8724Frequency: 4 issues/year

The Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.

With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Shaping the Future of Digestive and Liver Health Research
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Elevating clinical practices through open access knowledge.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

HEPATOLOGY

Connecting experts to foster collaboration in hepatology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0270-9139Frequency: 12 issues/year

HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.

Canadian Journal of Gastroenterology and Hepatology

Fostering Collaboration in Gastrointestinal and Liver Studies
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Hepatitis Monthly

Unveiling breakthroughs in hepatitis management.
Publisher: BRIEFLANDISSN: 1735-143XFrequency: 12 issues/year

Hepatitis Monthly, published by BRIEFLAND in the Netherlands, is a pivotal journal in the fields of hepatology and infectious diseases. Established in 2007, it continues to make significant contributions to the understanding and management of hepatitis and related viral infections with a publication timeline extending through to 2024. Aiming to disseminate high-quality research, the journal serves as a forum for groundbreaking studies and innovations essential for healthcare professionals, researchers, and students alike. While it currently holds Q4 rankings in both hepatology and infectious disease categories, its ongoing commitment to addressing pressing health issues makes it an important resource in the academic community. Although it operates under a traditional access model, Hepatitis Monthly not only publishes original research articles, reviews, and case studies but also encourages the exchange of knowledge that helps shape future research directions and clinical practices. As it continues to explore the complexities surrounding viral hepatitis, this journal invites researchers to contribute to its mission of advancing scientific understanding and improving patient care.